Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients
PROTECT-05
1 other identifier
interventional
12
1 country
1
Brief Summary
This is a monocentric, prospective and interventional study aimed to investigating the physiological responses of eccentric compared to concentric cycling realized 1) at the same metabolic demand and 2) at the same mechanical power output. In order to compare the physiological responses between these two cycling modalities, 3 cycling sessions should be performed for each patient where concentric one will serve as reference / comparison to the eccentric one:
- Session (a): eccentric cycling
- Session (b): high intensity concentric cycling realized at the same mechanical power output than eccentric cycling
- Session (c): low intensity concentric cycling realized at the same metabolic demand than eccentric cycling The 3 sessions will be performed for each patient and order will be randomized.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Nov 2021
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 22, 2021
CompletedFirst Submitted
Initial submission to the registry
November 24, 2021
CompletedFirst Posted
Study publicly available on registry
December 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2022
CompletedMay 26, 2022
May 1, 2022
5 months
November 24, 2021
May 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Investigate the physiological responses of the eccentric cycling on the knee extensors muscles by changes of neuromuscular parameters
Measurement of neuromuscular fatigue via change in maximal voluntary isometric contraction of the knee extensors muscles registered via a force sensor.
24 hours after pedaling sessions
Secondary Outcomes (8)
Comparison of muscle pain after eccentric in session (a) and after concentric modalities in session (b) and session (c)
24 hours after pedaling sessions
Comparison of central (identified as a decrease in voluntary activation, VA) fatigue after eccentric in session (a) and after concentric modalities in session (b) and session (c)
24 hours after pedaling sessions
Comparison of peripheral (identified as a decrease in the quadriceps twitch muscle contractile capacities, Qtw) fatigue after eccentric in session (a) and after concentric modalities in session (b) and session (c)
24 hours after pedaling sessions
Comparison of muscle thickness measured via ultrasonography on the vastus lateralis muscle after eccentric modality in pedaling session (a) and after concentric modalities in pedaling sessions (b) and (c)
24 hours after pedaling sessions
Comparison of muscle fibers pennation angle measured via ultrasonography on the vastus lateralis muscle after eccentric modality in pedaling session (a) and after concentric modalities in pedaling sessions (b) and (c)
24 hours after pedaling sessions
- +3 more secondary outcomes
Study Arms (1)
eccentric cycling compared to concentric cycling
EXPERIMENTALEvery participant will perform the same protocol and will participated to the 3 experimental sessions (a, b and c) of the assigned intervention.
Interventions
High intensity concentric cycling realized at the same mechanical power output than eccentric cycling
Low intensity concentric cycling realized at the same metabolic demand than eccentric cycling
Eligibility Criteria
You may qualify if:
- Woman who completed (neo)adjuvant chemotherapy since less than 1 year for a breast cancer
- Woman under hormonotherapy, or menopausal woman, or woman in amenorrhea
You may not qualify if:
- Pregnant and nursing woman
- psychiatric, musculoskeletal or neurological disorders
- presenting at least one contraindication to the use of the transcranial magnetic stimulation
- presenting at least one contraindication to the realisation of the maximum effort test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de cancérologie Strasbourg Europe
Strasbourg, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roland SCHOTT, MD
Institut de cancérologie Strasbourg Europe
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2021
First Posted
December 21, 2021
Study Start
November 22, 2021
Primary Completion
April 28, 2022
Study Completion
April 28, 2022
Last Updated
May 26, 2022
Record last verified: 2022-05